Literature DB >> 27392660

Evaluating the efficiency of desflurane reflection in two commercially available reflectors.

Hagen Bomberg1, Marcel Wessendorf2, Martin Bellgardt3, Max Veddeler2, Stefan Wagenpfeil4, Thomas Volk2, Heinrich V Groesdonk2, Andreas Meiser5.   

Abstract

With the AnaConDa™ and the MIRUS™ system, volatile anesthetics can be administered for inhalation sedation in intensive care units. Instead of a circle system, both devices use anesthetic reflectors to save on the anesthetic agent. We studied the efficiency of desflurane reflection with both devices using different tidal volumes (VT), respiratory rates (RR), and 'patient' concentrations (CPat) in a bench study. A test lung was ventilated with four settings (volume control, RR × VT: 10 × 300 mL, 10 × 500 mL, 20 × 500 mL, 10 × 1000 mL). Two different methods for determination of reflection efficiency were established: First (steady state), a bypass flow carried desflurane into the test lung (flowin), the input concentration (Cin) was varied (1-17 vol%), and the same flow (flowex, Cex) was suctioned from the test lung. After equilibration, CPat was stored online and averaged; efficiency [%] was calculated [Formula: see text]. Second (washout), flowin and flowex were stopped, the decline of CPat was measured; efficiency was calculated from the decay constant of the exponential regression equation. Both measurement methods yielded similar results (Bland-Altman: bias: -0.9 %, accuracy: ±5.55 %). Efficiencies higher than 80 % (>80 % of molecules exhaled are reflected) could be demonstrated in the clinical range of CPat and VT. Efficiency inversely correlates with the product of CPat and VT which can be imagined as the volume of anesthetic vapor exhaled by the patient in one breath, but not with the respiratory frequency. Efficiency of the AnaConDa™ was higher for each setting compared with the MIRUS™. Desflurane is reflected by both reflectors with efficiencies high enough for clinical use.

Entities:  

Keywords:  AnaConDa™; Efficiency reflection; Intensive care unit (ICU); MIRUS™; Sedation

Mesh:

Substances:

Year:  2016        PMID: 27392660     DOI: 10.1007/s10877-016-9902-0

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  10 in total

Review 1.  Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit.

Authors:  Andreas Meiser; H Laubenthal
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2005-09

2.  The predictive performance of a pharmacokinetic model for manually adjusted infusion of liquid sevofluorane for use with the Anesthetic-Conserving Device (AnaConDa): a clinical study.

Authors:  Javier F Belda; Marina Soro; Rafael Badenes; Andreas Meiser; María Luisa García; Gerardo Aguilar; Francisco J Martí
Journal:  Anesth Analg       Date:  2008-04       Impact factor: 5.108

3.  Comparing charcoal and zeolite reflection filters for volatile anaesthetics: A laboratory evaluation.

Authors:  Louise W Sturesson; Jan O Frennström; Marcella Ilardi; Peter Reinstrup
Journal:  Eur J Anaesthesiol       Date:  2015-08       Impact factor: 4.330

4.  Survival after long-term isoflurane sedation as opposed to intravenous sedation in critically ill surgical patients: Retrospective analysis.

Authors:  Martin Bellgardt; Hagen Bomberg; Jenny Herzog-Niescery; Burkhard Dasch; Heike Vogelsang; Thomas P Weber; Claudia Steinfort; Waldemar Uhl; Stefan Wagenpfeil; Thomas Volk; Andreas Meiser
Journal:  Eur J Anaesthesiol       Date:  2016-01       Impact factor: 4.330

5.  Desflurane compared with propofol for postoperative sedation in the intensive care unit.

Authors:  A Meiser; C Sirtl; M Bellgardt; S Lohmann; A Garthoff; J Kaiser; P Hügler; H J Laubenthal
Journal:  Br J Anaesth       Date:  2003-03       Impact factor: 9.166

6.  Prolonged isoflurane sedation of intensive care unit patients with the Anesthetic Conserving Device.

Authors:  Peter V Sackey; Claes-Roland Martling; Fredrik Granath; Peter J Radell
Journal:  Crit Care Med       Date:  2004-11       Impact factor: 7.598

7.  Renal integrity in sevoflurane sedation in the intensive care unit with the anesthetic-conserving device: a comparison with intravenous propofol sedation.

Authors:  Kerstin D Röhm; Andinet Mengistu; Joachim Boldt; Jochen Mayer; Grietje Beck; Swen N Piper
Journal:  Anesth Analg       Date:  2009-06       Impact factor: 5.108

8.  Technical performance and reflection capacity of the anaesthetic conserving device--a bench study with isoflurane and sevoflurane.

Authors:  Andreas Meiser; Martin Bellgardt; Javier Belda; Kerstin Röhm; Heinz Laubenthal; Clemens Sirtl
Journal:  J Clin Monit Comput       Date:  2009-02-03       Impact factor: 2.502

9.  Elderly patients recover more rapidly from desflurane than from isoflurane anesthesia.

Authors:  J A Bennett; N Lingaraju; J C Horrow; T McElrath; M M Keykhah
Journal:  J Clin Anesth       Date:  1992 Sep-Oct       Impact factor: 9.452

10.  A novel device for target controlled administration and reflection of desflurane--the Mirus™.

Authors:  H Bomberg; M Glas; V H Groesdonk; M Bellgardt; J Schwarz; T Volk; A Meiser
Journal:  Anaesthesia       Date:  2014-07-09       Impact factor: 6.955

  10 in total
  6 in total

Review 1.  [New technical developments for inhaled sedation].

Authors:  A Meiser; H Bomberg; T Volk; H V Groesdonk
Journal:  Anaesthesist       Date:  2017-04       Impact factor: 1.041

2.  Sedation with inhaled agents in the ICU: what are we waiting for?

Authors:  Jan Hendrickx; Jan Poelaert; Andre De Wolf
Journal:  J Clin Monit Comput       Date:  2018-06-15       Impact factor: 2.502

3.  Volumetric and reflective device dead space of anaesthetic reflectors under different conditions.

Authors:  Hagen Bomberg; Max Veddeler; Thomas Volk; Heinrich V Groesdonk; Andreas Meiser
Journal:  J Clin Monit Comput       Date:  2018-01-27       Impact factor: 2.502

4.  Comparison of the use of AnaConDa® versus AnaConDa-S® during the post-operative period of cardiac surgery under standard conditions of practice.

Authors:  Jose Miguel Marcos-Vidal; María Merino; Rafael González; Cristina García; Saleta Rey; Irene Pérez
Journal:  J Clin Monit Comput       Date:  2019-02-19       Impact factor: 2.502

5.  Anesthetic gas consumption with target-controlled administration versus a semi-closed circle system with automatic end-tidal concentration control in an artificial lung model.

Authors:  Martin Bellgardt; Vladimir Vinnikov; Adrian Iustin Georgevici; Livia Procopiuc; Thomas Peter Weber; Andreas Meiser; Jennifer Herzog-Niescery; Dominik Drees
Journal:  Med Gas Res       Date:  2022 Oct-Dec

6.  Use of MIRUS™ for MAC-driven application of isoflurane, sevoflurane, and desflurane in postoperative ICU patients: a randomized controlled trial.

Authors:  Martin Bellgardt; Adrian Iustin Georgevici; Mitja Klutzny; Dominik Drees; Andreas Meiser; Philipp Gude; Heike Vogelsang; Thomas Peter Weber; Jennifer Herzog-Niescery
Journal:  Ann Intensive Care       Date:  2019-10-16       Impact factor: 6.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.